v3.26.1
Note B - CB Oncology Partners (Details Textual) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Income from investments in unconsolidated entities, net $ 0 $ 0
CB Oncology Partners ("CBOP") [Member]    
Financing Receivable, after Allowance for Credit Loss 525,000  
CB Oncology Partners ("CBOP") [Member]    
Income from investments in unconsolidated entities, net $ 36,000 $ 109,000